Pantoprazole Decreases Cell Viability and Function of Human Osteoclasts In Vitro
Proton pump inhibitors (PPIs) are commonly prescribed drugs that decrease stomach acidity and are thus often used to treat gastroesophageal reflux disease and as a preventative agent for the adverse effects of nonsteroidal anti-inflammatory drugs on the stomach mucosa. In recently published literatu...
Saved in:
Main Authors: | Markus Prause, Claudine Seeliger, Marina Unger, Elizabeth Rosado Balmayor, Martijn van Griensven, Alexander Tobias Haug |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2015/413097 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
miR-125b differentially impacts mineralization in dexamethasone and calcium-treated human mesenchymal stem cells
by: Virginie Joris, et al.
Published: (2025-03-01) -
Pantoprazole – safety in drug-drug interaction
by: E. V. Shikh, et al.
Published: (2012-09-01) -
In Vitro Assay to Examine Osteoclast Resorptive Activity Under Estrogen Withdrawal
by: Cara Fiorino, et al.
Published: (2025-01-01) -
Effect of Allium cepa L. on Lipopolysaccharide-Stimulated Osteoclast Precursor Cell Viability, Count, and Morphology Using 4′,6-Diamidino-2-phenylindole-Staining
by: Tatiane Oliveira, et al.
Published: (2014-01-01) -
Current Potential of Pantoprazole in Treatment and Prevention of Gastrointestinal Diseases
by: A. A. Sheptulin, et al.
Published: (2021-04-01)